We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleHow much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!AuthorsEisenberger MA; Nelson WGPublicationJournal of the National Cancer Institute, 1996, Vol 88, Issue 12, p779ISSN0027-8874Publication typearticleDOI10.1093/jnci/88.12.779